COVID-19患者入院时肺栓塞患病率:预测评分与家庭治疗是否有用?
本文为致编辑信,评论Jevnikar等的前瞻性多中心研究。该研究对2020年4月15日至5月23日法国三家三级医院连续住院的COVID-19成人门诊患者行CTPA,仅排除有禁忌者,旨在明确入院时PE实际患病率。作者认为该研究首次提供可靠证据,表明COVID-19患者入院时PE患病率即已较高。
要点
- 既往研究仅在少数疑似PE患者中行CTPA,且检查时间不一,无法区分PE是COVID-19并发症还是住院后果。
- Jevnikar等对连续住院COVID-19患者入院时行CTPA,仅排除碘对比剂禁忌者,减少了选择偏倚。
- 该研究证实COVID-19患者入院时PE患病率已较高,支持入院时即评估PE风险。
核心结论
- COVID-19患者入院时肺栓塞患病率已较高,既往研究因CTPA选择偏倚和时间不一而低估或混淆了此关联。
研究设计与样本
- Jevnikar等为前瞻性多中心研究,纳入2020年4月15日至5月23日法国三家三级医院连续住院的COVID-19成人门诊患者,入院时行CTPA,仅排除检查禁忌者。
主要发现
- 该研究提供了COVID-19住院患者入院时PE实际患病率的精确信息。
- 既往研究仅在少数临床疑似PE患者中行CTPA,且检查时间贯穿住院期,无法判断PE是COVID-19并发症还是住院后果。
临床怎么用
- 对COVID-19住院患者应关注入院时肺栓塞风险,但预测评分与家庭治疗的作用尚需进一步研究。
局限性
- 本文为致编辑信,未报告Jevnikar等研究的具体样本量、PE患病率数值及置信区间。
- 原文未报告预测评分及家庭治疗在COVID-19合并PE中的具体应用数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Further confirmation that COVID-19 patients are at high risk of venous thromboembolism https://bit.ly/2OfPR5A We read with interest the research letter recently authored by Jevnikar et al. [1] about the prevalence of pulmonary embolism (PE) in patients with coronavirus disease 2019 (COVID-19) at the time of hospital admission. In this prospective multicentre study, all consecutive adult outpatients that were hospitalised with a diagnosis of COVID-19 in three tertiary French hospitals between 15 April and 23 May 2020 underwent computed tomography pulmonary angiography (CTPA). Only patients with contraindications to the examination (mainly due to contraindication for iodinated contrast administration) were excluded. The strength of this study is that it finally provides precise information regarding the actual prevalence of PE in hospitalised COVID-19 patients. Over the past year, we have been bombarded almost daily with a seemingly infinite amount of data on the increased rate of venous thromboembolism (VTE) in COVID-19 patients, but all the studies available so far had the insurmountable flaw that CTPA was performed only in a minority of cases and mainly in patients with clinical suspicion of PE [2]. Another flaw of such previous studies was that CTPA was performed at various time-points during hospitalisation and, therefore, it was not possible to establish whether PE was an actual complication of COVID-19 or a consequence of the hospitalisation itself. In this scenario, the report of Jevnikar et al. [1] finally allows us to claim with substantiation that the prevalence of PE is high even at time of hospital admission in patients with COVID-19.
引用
- Porfidia A, Pola E, Pola R, et al. Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: is there a role for pre-test probability scores and home treatment? Eur Respir J. 2021. PMID: 33833035. doi:10.1183/13993003.00785-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。